For more information please contact the Press Office:
Tel: +49 6221 387-8443
Tel: +49 6221 387-8726
Heidelberg, 23 December 2019 EMBL co-develops new method that could facilitate cancer diagnosis Researchers led by EMBL Heidelberg and the Center for Bioinformatics at Saarland University have developed a cheaper and faster method to check for genetic differences in individual cells, which outperforms existing techniques with respect to the information received. This new method could become a new standard in single cell research, and potentially for clinical diagnosis in disease genetics, including cancer. The results have been published in Nature Biotechnology.
Heidelberg, 23 December 2019 Innovative method delivers new insights into the stem cell microenvironment Researchers from EMBL and the German Cancer Research Center (DKFZ) in Heidelberg, Germany, have developed new methods to reveal the three-dimensional organisation of bone marrow at a single cell level. Since bone marrow harbours blood stem cells responsible for life-long blood generation, these results and the new method provides a novel scientific basis to study blood cancer. The results have been published in Nature Cell Biology.
Hinxton, 13 December 2019 Machine learning finds functional human phosphosites Researchers at the EMBL’s European Bioinformatics Institute (EMBL-EBI) have created the largest reference phosphoproteome to date of almost 120 000 human phosphosites. To identify those most likely to be critical, they used a machine learning approach capable of ranking them according to functional importance.
Heidelberg, 2 December 2019 EMBL and Leica sign open innovation collaboration agreement EMBL often cooperates with industry partners, and has cooperated successfully with Leica for many years. Based on this strong partnership, Leica is among the companies supporting the upcoming EMBL Imaging Centre, which is currently under construction at the EMBL campus in Heidelberg, Germany.
Heidelberg, 7 November 2019 Integrating imaging research across Europe The European Commission has officially established Euro-BioImaging – which provides life scientists with open access to a broad range of technologies and resources in biological and biomedical imaging – as a European Research Infrastructure Consortium (ERIC). Since Euro-BioImaging was initiated at EMBL in 2007, this adds yet another remarkable achievement to EMBL’s mission of integrating European life sciences.
Heidelberg, 4 November 2019 EMBL spins the Sleeping Beauty transposase EMBL scientists have developed a new variant of the Sleeping Beauty transposase. It has dramatically improved biochemical features, including enhanced stability and intrinsic cell penetrating properties. This transposase can be used for genome engineering of stem cells and therapeutic T cells. As such it is extremely valuable for use in regenerative medicine and cancer immunotherapy. The underlying genome engineering procedures will in the future also reduce costs and improve the safety of genome modifications.
Barcelona, 20 September 2019 Discover the research schooner Tara and her new microplastics mission in the Barcelona harbour on 4 October The European Molecular Biology Laboratory (EMBL) in Barcelona and the Tara Ocean Foundation invite you to a press conference on the rising threat of microplastics in European rivers and the ocean
Grenoble, 16 September 2019 Discover the research schooner Tara and her new microplastics mission in the Old Port of Marseille on 27 September The Tara Ocean Foundation and the European Molecular Biology Laboratory (EMBL) in Grenoble invite journalists to a press conference in Marseille on the rising threat of microplastics in European rivers and the ocean. The press conference also provides the opportunity to discover the interdisciplinary research of EMBL, major partner of the Tara expeditions and the place where the idea for Tara Oceans (2009–2013) was born.
Hinxton, 13 September 2019 B cells linked to immunotherapy Researchers at EMBL’s European Bioinformatics Institute and the Medical University of Vienna have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.
Policy regarding use
Press and Picture Releases
EMBL press and picture releases including photographs, graphics, movies and videos are copyrighted by EMBL. They may be freely reprinted and distributed for non-commercial use via print, broadcast and electronic media, provided that proper attribution to authors, photographers and designers is made.